Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH3 (edelfosine) and amphotericin B

Acta Tropica

Volumn 81, Issue 2, 2002, Pages 151-157

  Escobar, Patricia ^a   Matu, Sangeeta ^a   Marques, Cláudia ^a   Croft, Simon L ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Alkyl lysophospholipids; Amphotericin B; ET 18 OCH3; Hexadecylphosphocholine; Leishmania species

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; EDELFOSINE; MILTEFOSINE;

LEISHMANIASIS;

AMASTIGOTE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; IN VITRO STUDY; LEISHMANIA; LEISHMANIA AETHIOPICA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA PANAMENSIS; LEISHMANIA TROPICA; LEISHMANIASIS; NONHUMAN; PROMASTIGOTE; SPECIES DIFFERENCE;

AMPHOTERICIN B; ANIMALS; ANTIPROTOZOAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; LEISHMANIA; MACROPHAGES, PERITONEAL; MICE; PHOSPHOLIPID ETHERS; PHOSPHORYLCHOLINE; SPECIES SPECIFICITY;

LEISHMANIA AETHIOPICA; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; LEISHMANIA PANAMENSIS; LEISHMANIA TROPICA;

EID: 0036150927     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(01)00197-8     Document Type: Article

References (32)

1. Cytotoxicity of ester and ether lysophospholipids on Leishmania donovani promastigotes
2. The in vitro susceptibility of macrophages infected with amastigotes of Leishmania spp. to pentavalent antimonial drugs and other compounds with special relevance to cutaneous isolates
3. Comparative effects of 4-amino pyrazolo pyrimidine, its 2′-deoxyriboside derivative, and allopurinol on in vitro growth of American Leishmania species
4. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes
5. Lipids of Leishmania promastigotes
6. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
7. Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro
8. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis
9. Analogs of alkyllysophospholipids: Chemistry, effects on the molecular level and their consequences for normal and malignant cells
10. Correlation of ether-lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine
11. Anti-parasitic drugs: The current status
12. The activity of alkyl phosphorylcholines and related derivatives against Leishmania donovani
13. The activities of four anti-cancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei
14. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro
15. Effect of drugs on various Leishmania isolates and succinic dehydrogenase inhibition
16. Role of cell cholesterol in modulating anti-neoplastic ether-lipid uptake, membrane effects and cytotoxicity
17. Sterols of Leishmania species. Implications for biosynthesis
18. Drug resistance in leishmaniasis: Its implication in systemic chemotherapy of cutaneous and mucocutaneous disease
19. Miltefosine-The long-awaited therapy for visceral leishmaniasis?
20. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis
21. Hexadecylphosphocholine: Oral treatment of visceral leishmaniasis in mice
22. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in BALB/c mice
23. Ether-lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues
24. Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania
25. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
26. The sensitivity of Leishmania species to aminosidine
27. Allopurinol ribonucleoside as an anti-leishmanial agent. Biological effects, metabolism, and enzymatic phosphorylation
28. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine: Comparative study with azole-susceptible Leishmania mexicana promastigotes
29. Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruzi
30. Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis
31. Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent
32. Trial of oral miltefosine for visceral leishmaniasis